Cargando…
Development of targeted therapies in treatment of glioblastoma
Glioblastoma (GBM) is a type of tumor that is highly lethal despite maximal therapy. Standard therapeutic approaches provide modest improvement in progression-free and overall survival, necessitating the investigation of novel therapies. Oncologic therapy has recently experienced a rapid evolution t...
Autores principales: | Xu, Yuan-Yuan, Gao, Pei, Sun, Ying, Duan, You-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607828/ https://www.ncbi.nlm.nih.gov/pubmed/26487967 http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0020 |
Ejemplares similares
-
Hedgehog signaling regulates the development and treatment of glioblastoma
por: Wang, Hongping, et al.
Publicado: (2022) -
Development of glioblastoma organoids and their applications in personalized therapy
por: Xu, Can, et al.
Publicado: (2023) -
The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma
por: Liu, Xudong, et al.
Publicado: (2023) -
Targeting CDK9 for the Treatment of Glioblastoma
por: Ranjan, Alice, et al.
Publicado: (2021) -
Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword
por: Wu, Mengwan, et al.
Publicado: (2022)